Cordlife unveils new metabolic screening test aimed at India's middle-class market
CORDLIFE Group, a provider of umbilical cord blood and tissue banking services, announced that its Indian subsidiary, Cordlife Sciences India, has introduced an advanced non-invasive metabolic screening service.
Known as MetaScreen, it is a set of metabolic screening test specially designed for both newborn babies and adults, and is able to detect up to 110 inborn errors of metabolism from urine samples.
The firm said metabolic disorders are usually not apparent at the time of birth.
If left untreated, the baby can develop irreversible damages like neurological impairment and physical deformities.